Main Article Content
Abstract
Misoprostol is licensed to treat gastric ulcers but now it is widely used for a variety of indications in osbtetrics and gynecology. This is called ‘off-label’ use. Misoprostol is cheap, stable at room temperature and easily to access it. Available in tablet form, it can be administred vaginally, rectally, sublingually and bucally. This review explains benefit and risk of misoprostol in obstetric and gynecology field.
Article Details
License
Authors who publish in the Jurnal Kedokteran dan Kesehatan Indonesia agree to the following terms:
- Authors retain copyright and grant Jurnal Kedokteran dan Kesehatan Indonesia right of first publication with the work simultaneously licensed under a Creative Commons Attribution Licence that allows others to adapt (remix, transform, and build) upon the work non-commercially with an acknowledgement of the work's authorship and initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
- Authors are permitted to share (copy and redistribute) the journal's published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Jurnal Kedokteran dan Kesehatan Indonesia.
How to Cite
Desrini, S. (2016). The benefit and risk of misoprostol use: in obstetrics and gynecology. JKKI : Jurnal Kedokteran Dan Kesehatan Indonesia, 7(1), 25–29. https://doi.org/10.20885/JKKI.Vol7.Iss1.art5